Biocatalysts Market - Global Outlook & Forecast 2022-2027

List of Tables

The global biocatalysts market is expected to grow at a CAGR of 5.60% during 2021-2027.

MARKET SYNOPSIS

Biocatalysts are substances, specifically enzymes, that activate or speed up a biochemical reaction. Biocatalysts are used in chemical synthesis in various industries (such as pharmaceuticals, food & beverages, animal nutrition, household, and others). In the pharmaceutical industry, biocatalysts help in manufacturing drugs for DNA/RNA treatment, cancer, heart-related disease, and other treatments.

Increasing demand for biobased products drives the biocatalysts market. Due to emerging technology, sustainability is growing all over the world. In the pharmaceutical industry, companies have started using biobased drugs to improve the quality of products, making the pharmaceutical biocatalysts market grow rapidly. Thus, top companies follow the expansion strategy for acquiring a greater biocatalysts market share. The food & beverages industry is rising due to the increasing consumption of food & beverages, thus increasing the demand for biocatalysts in the global industry.

MARKET TRENDS & DRIVERS

Increase in Food Consumption Due to Growth in Population

The food industry includes four major sectors - producers, marketers, processors, and farm services. During the Covid 19, the demand for food supplies increased, resulting in the food industry's growth. Enzymes are used in the food industry as a preservative, the best substitute for chemical preservatives. They improve the quality of products such as starch, fruit juices, cheese, animal feed, and beer & wine. From the application perspective, the demand for animal feed is increasing due to higher poultry, meat, and dairy consumption.

Increasing Demand from Pharmaceutical Industry

The pharmaceutical industry's revenue is increasing yearly due to increasing demand for the drugs used for manufacturing pharmaceutical products. In past years, the Chinese pharma industry has been on the top in terms of growth rate. The consumption of pharmaceutical products is growing due to changes in clinical practices and increasing chronic and aging-related issues.
The lowering of regulatory barriers for new drugs in the US causes an increased demand for pharma sector products globally. During the Covid-19 pandemic, the highest demand for pharmaceutical products was observed. The demand for new drugs is still high owing to the recurrence of new variants of Covid-19 in various countries. The demand for pharmaceutical products is also increasing in developing countries such as India, China, and Brazil, among others owing to the emergence of Covid-19 variants, lifestyle diseases, and an aging population. Biocatalysts are used in the manufacturing processes of antibiotics to treat such diseases. And with a growing global pharmaceutical industry, the biocatalysts market is also growing.

MARKET RESTRAINT

Technical Barriers Affecting Industry

Biocatalysis is a process that accelerates the chemical process by using biomolecules. It includes mild reaction and high selectivity conditions. Therefore, biocatalysts play an important role in the chemical industry and are gaining relevance in industrial applications. But, there is difficulty in finding the accurate protein structure of biocatalysts. The process is time-consuming and requires more catalysts to fulfilling the chemical reaction process. For the biocatalysts manufacturing process, specific conditions such as new substrate, new concentration, and other conditions are required which are not found easily in nature. Thus, increasing the cost of producing the biocatalysts.

SEGMENTATION ANALYSIS

INSIGHTS BY TYPE

Carbohydrases is the largest segment by type in the global biocatalysts market and is expected to reach USD 231.03 million by 2027. Carbohydrases are mainly used in the food industry as biocatalysts. Most of these biocatalysts used in the food industry are produced from fungi, yeast, and bacteria. Carbohydrases are used in milk products as digestion agents to reduce milk lactose. These are further classified into alpha, beta amylases, cellulases, glucosidase, pectinases, mannanases, galacto, and pullulanase.
The global proteases-based biocatalysts market was valued at USD 134.40 million in 2021 and is the second largest industry by type segment. The proteases are used in the cleaning, leather, and dairy industries. Based on the catalysis mechanism, the proteases are classified into further classes glutamic, aspartic, metalloproteases, threonine, cysteine, and serine proteases which activate the water molecule and attack the proteins.
Lipases are used in the catalysis of fats, which helps reduce their food content. These are derived from animal and plant enzymes used in various biological processes, which are used for inflammation, diet, and increasing metabolism. The lipases segment is expected to grow at a CAGR of 5.49% during the forecast period. These are used in esters and have high scope in biofuels. The increased demand for biofuels is due to the increasing prices of crude oil, which further increases the demand for lipases in the biocatalysts markets.

Segmentation by Type

Carbohydrases
Proteases
Polymerases & Nucleases
Lipases
Phytases
Other

INSIGHTS BY END-USE

The global biocatalysts market by end-use is categorized as pharmaceutical, food & beverages, animal nutrition, household, and others. The pharmaceutical is the largest segment by end-use and is expected to cross USD 215.42 million by 2027. Due to growth in the global population, the demand for pharmaceutical products is increasing. Due to which people are becoming more health conscious, pharmaceutical companies are focusing on increasing the bio-based content in drug formulations. In the pharmaceutical industry, biocatalysts are used for molecular biology, extraction of medically important compounds, diagnostic procedures, chemical pharmaceutical manufacturing, and deficiencies supplements.
The food & beverages segment is growing with a CAGR of 6.31 % during the forecast period and is the second largest segment by end-use. Biocatalysts have been used for hundreds of years in the food & beverages industry. Commercial biocatalysts are produced from microbial, plants, and animals. There is a massive demand for bakery biocatalysts in the industry for extending shelf life, mainly in Europe and North America. Biocatalyst manufacturing companies are developing new designs to improve bakery food quality.

Segmentation by End Use

Pharmaceutical
Food & Beverages
Animal Nutrition
Household
Others

GEOGRAPHICAL ANALYSIS

North America dominates the global biocatalysts market and is expected to grow at a CAGR of 6.27% during the forecast period. The region is the leading market for biocatalysts because of its rapidly developing infrastructure, readily increasing population, and growing demand from various industries such as food & beverage, pharmaceutical, animal nutrition, and household. The US and Canada are the two major countries dominating North America's biocatalyst market. The demand for biocatalysts in North America's pharmaceutical industry is increasing with the rise in pharma products and the presence of the world-leading ten pharmaceutical companies in the US.

APAC biocatalysts market is the second largest industry globally and is expected to grow the highest CAGR during the forecast period. With the changing technology & innovations in food & beverages, the demand for biocatalysts is increasing. Increasing health expenditure, increasing health consciousness, increasing new diseases, and others are the key factors for the growing pharmaceutical market, further contributing to the Asia Pacific industry.

Germany, Italy, France, and Spain are the major countries in the European biocatalyst market. The increasing consumption of biocatalysts is attributed to the rising per capita income in European countries. High spending on healthy food, attributed to people's health-conscious habits, and growing demand for food & beverages biocatalysts are significant market drivers in Europe.

Segmentation by Geography

APAC
- China
- India
- Japan
- South Korea
- Rest of APAC
North America
- US
- Canada
Europe
- Germany
- Spain
- France
- Italy
- Rest of Europe
Latin America
- Brazil
- Mexico
- Rest Of Latin America
Middle East & Africa
- South Africa
- South Arabia
- Rest of the Middle East & Africa

VENDOR LANDSCAPE

Some key players in the global biocatalysts market include DuPont (U.S.), AB Enzymes (Germany), BASF SE (Germany), Novozymes (Denmark), and DSM (Netherlands). These players have adopted strategies such as expansion, acquisitions, new product development, joint ventures, and others to increase their revenues in the biocatalysts market. Furthermore, other prominent companies such as Amano Enzymes (Japan), Dyadic International (U.S.), Codexis (U.S.), and others have invested considerable capital in R&D to develop biocatalysts-based products that will appeal to the customers. Therefore, these other prominent companies are giving tough competition to major companies.

The major companies follow a merger and acquisition strategy, giving them a competitive advantage to boost their market share. The key vendors have undertaken various strategies to grow in the global biocatalysts market. The growth in sustainable processes and innovations has challenged all companies globally. Investments in R&D, technological advancement, and environmental and economic challenges drive the demand for innovative and sustainable biocatalysts products.

Key Vendors

DuPont
BASF SE
DSM
AB Enzymes
Novozymes

Other Prominent Vendors

Chr Hansen Holding A/S
Codexis
Dyadic International Inc.
Amano Enzymes
Biocatalysts
Nature Bioscience Pvt Ltd.
Johnson Matthey
Advanced Enzymes Technologies
Zymtronix, Inc.
Nutritech
Hoffmann-La Roche Ltd (Roche CustomBiotech)
Aumenzymes
The Soufflet Group
Iosynth

Key Developments In The Global Biocatalysts Market:

In 2021 Novozymes bought majority stakes in the Mumbai (India) based Synergia Life Sciences company, a global leader in the microbiome therapeutic and vitamin k2-7 manufacturer and supplier.
DSM acquired the U.S.-based First Choice Ingredients company, a manufacturer of dairy-based flavorings. This deal gives the company fermentation and biotechnology solutions.

KEY QUESTIONS ANSWERED

1. What is the revenue from the global biocatalysts market?
2. What is the growth rate of the biocatalysts market?
3. Who are the key players in the global biocatalysts market?
4. What is the projected biocatalysts market by 2027?
5. What are the key driving factors in the global biocatalysts market?
6. Which region dominates the global biocatalysts Market?

Product Code: ARZ220931

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

6.1 INTRODUCTION
6.2 MARKET SYNOPSIS
- 6.2.1 ENABLER
- 6.2.2 OPPORTUNITIES
- 6.2.3 RESTRAINT
6.3 SEGMENT REVIEW
- 6.3.1 END-USERS
- 6.3.2 TYPE
6.4 GEOGRAPHY
6.5 COMPANIES AND STRATEGIES

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW
8.2 VALUE CHAIN ANALYSIS
- 8.2.1 RAW MATERIALS
- 8.2.2 BIOCATALYST MANUFACTURER
- 8.2.3 DISTRIBUTOR
- 8.2.4 APPLICATION
8.3 MACROECONOMIC FACTORS
- 8.3.1 PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRIES
- 8.3.2 FOOD & BEVERAGES INDUSTRY

9 MARKET OPPORTUNITIES & TRENDS

9.1 INCREASING DEMAND FROM PHARMACEUTICAL INDUSTRY
9.2 SOARING DEMAND FOR BIOFUEL
9.3 ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PRODUCTIVITY & PROFITABILITY
9.4 INCREASING USE OF CLEANING PRODUCTS

10 MARKET GROWTH ENABLERS

10.1 INCREASE IN FOOD CONSUMPTION DUE TO GROWING POPULATION
10.2 RISE IN DEMAND FOR PLANT-BASED PRODUCTS

11 MARKET GROWTH RESTRAINTS

11.1 TECHNICAL BARRIERS AFFECTING BIOCATALYSTS MARKET
11.2 HIGH COST & LACK OF AWARENESS OF BIOBASED PRODUCTS

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY

13 TYPE

13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CARBOHYDRASES
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
13.4 PROTEASES
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
13.5 POLYMERASES & NUCLEASES
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 MARKET BY GEOGRAPHY
13.6 LIPASES
- 13.6.1 MARKET OVERVIEW
- 13.6.2 MARKET SIZE & FORECAST
- 13.6.3 MARKET BY GEOGRAPHY
13.7 PHYTASES
- 13.7.1 MARKET OVERVIEW
- 13.7.2 MARKET SIZE & FORECAST
- 13.7.3 MARKET BY GEOGRAPHY
13.8 OTHERS
- 13.8.1 MARKET OVERVIEW
- 13.8.2 MARKET SIZE & FORECAST
- 13.8.3 MARKET BY GEOGRAPHY

14 END-USER

14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 PHARMACEUTICAL
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
14.4 FOOD & BEVERAGES
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
14.5 ANIMAL NUTRITION
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 MARKET BY GEOGRAPHY
14.6 HOUSEHOLD
- 14.6.1 MARKET OVERVIEW
- 14.6.2 MARKET SIZE & FORECAST
- 14.6.3 MARKET BY GEOGRAPHY
14.7 OTHERS
- 14.7.1 MARKET OVERVIEW
- 14.7.2 MARKET SIZE & FORECAST
- 14.7.3 MARKET BY GEOGRAPHY

15 GEOGRAPHY

15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.3 TYPE
- 16.3.1 MARKET SIZE & FORECAST
16.4 END-USER
- 16.4.1 MARKET SIZE & FORECAST
16.5 KEY COUNTRIES
16.6 US
- 16.6.1 MARKET SIZE & FORECAST
16.7 CANADA
- 16.7.1 MARKET SIZE & FORECAST

17 EUROPE

17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 TYPE
- 17.3.1 MARKET SIZE & FORECAST
17.4 END-USER
- 17.4.1 MARKET SIZE & FORECAST
17.5 KEY COUNTRIES
17.6 GERMANY
- 17.6.1 MARKET SIZE & FORECAST
17.7 FRANCE
- 17.7.1 MARKET SIZE & FORECAST
17.8 ITALY
- 17.8.1 MARKET SIZE & FORECAST
17.9 SPAIN
- 17.9.1 MARKET SIZE & FORECAST
17.10 REST OF EUROPE
- 17.10.1 MARKET SIZE & FORECAST

18 APAC

18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 TYPE
- 18.3.1 MARKET SIZE & FORECAST
18.4 END-USER
- 18.4.1 MARKET SIZE & FORECAST
18.5 KEY COUNTRIES
18.6 CHINA
- 18.6.1 MARKET SIZE & FORECAST
18.7 INDIA
- 18.7.1 MARKET SIZE & FORECAST
18.8 JAPAN
- 18.8.1 MARKET SIZE & FORECAST
18.9 SOUTH KOREA
- 18.9.1 MARKET SIZE & FORECAST
18.10 REST OF APAC
- 18.10.1 MARKET SIZE & FORECAST

19 MIDDLE EAST & AFRICA

19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 TYPE
- 19.3.1 MARKET SIZE & FORECAST
19.4 END-USER
- 19.4.1 MARKET SIZE & FORECAST
19.5 KEY COUNTRIES
19.6 SAUDI ARABIA
- 19.6.1 MARKET SIZE & FORECAST
19.7 SOUTH AFRICA
- 19.7.1 MARKET SIZE & FORECAST
19.8 REST OF MIDDLE EAST & AFRICA
- 19.8.1 MARKET SIZE & FORECAST

20 LATIN AMERICA

20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 TYPE
- 20.3.1 MARKET SIZE & FORECAST
20.4 END-USER
- 20.4.1 MARKET SIZE & FORECAST
20.5 KEY COUNTRIES
20.6 BRAZIL
- 20.6.1 MARKET SIZE & FORECAST
20.7 MEXICO
- 20.7.1 MARKET SIZE & FORECAST
20.8 REST OF LATIN AMERICA
- 20.8.1 MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

21.1 COMPETITION OVERVIEW

22 KEY COMPANY PROFILES

22.1 DUPONT
- 22.1.1 BUSINESS OVERVIEW
- 22.1.2 FINANCIAL OVERVIEW
- 22.1.3 PRODUCT OFFERINGS
- 22.1.4 KEY STRATEGIES
- 22.1.5 KEY STRENGTHS
- 22.1.6 KEY OPPORTUNITIES
22.2 BASF SE
- 22.2.1 BUSINESS OVERVIEW
- 22.2.2 FINANCIAL OVERVIEW
- 22.2.3 PRODUCT OFFERINGS
- 22.2.4 KEY STRATEGIES
- 22.2.5 KEY STRENGTHS
- 22.2.6 KEY OPPORTUNITY
22.3 DSM
- 22.3.1 BUSINESS OVERVIEW
- 22.3.2 FINANCIAL OVERVIEW
- 22.3.3 PRODUCT OFFERINGS
- 22.3.4 KEY STRATEGY
- 22.3.5 KEY STRENGTHS
- 22.3.6 KEY OPPORTUNITY
22.4 AB ENZYMES
- 22.4.1 BUSINESS OVERVIEW
- 22.4.2 FINANCIAL OVERVIEW
- 22.4.3 PRODUCT OFFERINGS
- 22.4.4 KEY STRATEGIES
- 22.4.5 KEY STRENGTHS
- 22.4.6 KEY OPPORTUNITIES
22.5 NOVOZYMES
- 22.5.1 BUSINESS OVERVIEW
- 22.5.2 FINANCIAL OVERVIEW
- 22.5.3 PRODUCT OFFERINGS
- 22.5.4 KEY STRATEGIES
- 22.5.5 KEY STRENGTHS
- 22.5.6 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

23.1 CHR. HANSEN HOLDING A/S
- 23.1.1 COMPANY OVERVIEW
- 23.1.2 BUSINESS OVERVIEW
- 23.1.3 PRODUCT OFFERINGS
23.2 CODEXIS
- 23.2.1 COMPANY OVERVIEW
- 23.2.2 BUSINESS OVERVIEW
- 23.2.3 PRODUCT OFFERINGS
23.3 DYADIC INTERNATIONAL INC.
- 23.3.1 COMPANY OVERVIEW
- 23.3.2 BUSINESS OVERVIEW
- 23.3.3 PRODUCT OFFERINGS
23.4 AMANO ENZYME INC.
- 23.4.1 COMPANY OVERVIEW
- 23.4.2 BUSINESS OVERVIEW
- 23.4.3 PRODUCT OFFERINGS
23.5 BIOCATALYSTS
- 23.5.1 COMPANY OVERVIEW
- 23.5.2 BUSINESS OVERVIEW
- 23.5.3 PRODUCT OFFERINGS
23.6 NATURE BIOSCIENCE
- 23.6.1 COMPANY OVERVIEW
- 23.6.2 BUSINESS OVERVIEW
- 23.6.3 PRODUCT OFFERINGS
23.7 JOHNSON MATTHEY
- 23.7.1 COMPANY OVERVIEW
- 23.7.2 BUSINESS OVERVIEW
- 23.7.3 PRODUCT OFFERINGS
23.8 ADVANCED ENZYMES TECHNOLOGIES
- 23.8.1 COMPANY OVERVIEW
- 23.8.2 BUSINESS OVERVIEW
- 23.8.3 PRODUCT OFFERINGS
23.9 ZYMTRONIX, INC.
- 23.9.1 COMPANY OVERVIEW
- 23.9.2 PRODUCT OFFERINGS
23.10 NUTRITECH
- 23.10.1 COMPANY OVERVIEW
- 23.10.2 PRODUCT OFFERINGS
23.11 F. HOFFMANN-LA ROCHE LTD (ROCHE CUSTOMBIOTECH)
- 23.11.1 COMPANY OVERVIEW
- 23.11.2 BUSINESS OVERVIEW
- 23.11.3 PRODUCT OFFERINGS
23.12 AUMENZYMES
- 23.12.1 COMPANY OVERVIEW
- 23.12.2 PRODUCT OFFERINGS
23.13 SOUFFLET GROUP
- 23.13.1 COMPANY OVERVIEW
- 23.13.2 BUSINESS OVERVIEW
- 23.13.3 PRODUCT OFFERINGS
23.14 IOSYNTH
- 23.14.1 COMPANY OVERVIEW
- 23.14.2 BUSINESS OVERVIEW
- 23.14.3 PRODUCT OFFERINGS

24 REPORT SUMMARY

24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

25.1 MARKET BY END-USER
- 25.1.1 PHARMACEUTICAL
- 25.1.2 FOOD & BEVERAGE
- 25.1.3 ANIMAL NUTRITION
- 25.1.4 HOUSEHOLD
- 25.1.5 OTHERS
25.2 MARKET BY TYPE
- 25.2.1 CARBOHYDRASES
- 25.2.2 PROTEASES
- 25.2.3 POLYMERASES & NUCLEASES
- 25.2.4 LIPASES
- 25.2.5 PHYTASES
- 25.2.6 OTHER

26 GEOGRAPHY

26.1 NORTH AMERICA
- 26.1.1 TYPE
- 26.1.2 END-USER
26.2 EUROPE
- 26.2.1 TYPE
- 26.2.2 END-USER
26.3 APAC
- 26.3.1 TYPE
- 26.3.2 END-USER
26.4 MIDDLE EAST & AFRICA
- 26.4.1 TYPE
- 26.4.2 END-USER
26.5 LATIN AMERICA
- 26.5.1 TYPE
- 26.5.2 END-USER

27 APPENDIX

27.1 ABBREVIATIONS